Endothelial cell apoptotic genes associated with the pathogenesis of thrombotic microangiopathies: An application of oligonucleotide genechip technology

Microvascular Research

Volumn 62, Issue 2, 2001, Pages 83-93

  Kim, Jiyun ^a   Wu, Hong ^a   Hawthorne, Lesleyann ^b   Rafii, Shahin ^a   Laurence, Jeffrey ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Apoptosis; Endothelial cell; Genechip; Thrombotic microangiopathies

Indexed keywords

FAS ANTIGEN; INTERLEUKIN 1BETA CONVERTING ENZYME; OLIGONUCLEOTIDE; PROTEIN BCL X; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VASCULOTROPIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DEVICE; DNA MICROARRAY; ENDOTHELIUM CELL; GENE; GENE EXPRESSION SYSTEM; GENOTYPE; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TECHNOLOGY; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASCULAR ENDOTHELIUM;

EID: 0034834118     PISSN: 00262862     EISSN: None     Source Type: Journal    
DOI: 10.1006/mvre.2001.2326     Document Type: Article

References (39)

1. Manifestations resembling thrombotic microangiopathy in patients with advanced human immunodeficiency virus (HIV) disease in a cytomegalovirus prophylaxis trial (ACTG 204)
2. Thrombotic thrombocytopenic purpura associated with ticlopidine
3. Thrombotic thrombocytopenic purpura associated with clopidogrel
4. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
5. Vascular endothelial growth factor C induces angiogenesis in vivo
6. Cox-2, iNOS and p53 as play-makers of tumor angiogenesis
7. Endothelial cells in physiology and in the pathophysiology of vascular disorders
8. Enhanced endothelial cell apoptosis in splenic tissues of patients with thrombotic thrombocytopenic purpura
9. To die or not to die - The quest of the TRAIL receptors
10. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays
11. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL
12. Von Willabrand factor proteolysis in thrombotic thrombocytopenic purpura
13. The arginine-nitric oxide pathway in thrombotic microangiopathy
14. Human lung microvessel endothelial cells: Isolation, culture, and characterization
15. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR)
16. Apoptosis of microvascular endothelial cells in the pathophysiology of thrombotic thrombocytopenic purpura/sporadic hemolytic uremic syndrome
17. Plasma from patients with idiopathic and human immunodeficiency virus-associated thrombotic thrombocytopenic pupura induces apoptosis in microvascular endothelial cells
18. High density synthetic oligonucleotide arrays
19. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL
20. Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta
21. The extracellular matrix as a cell survival factor
22. Role of caspases 1 and 3 and Bcl-2-related molecules in endothelial cell apoptosis associated with thrombotic microangiopathies
23. Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells
24. Prediction of the coding sequences of unidentified human genes. III. The coding sequences of 40 new genes (KIAA0081-KIAA0120) deduced by analysis of cDNA clones from human cell line KG-1
25. Prediction of the coding sequences of unidentified human genes. IV. The coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by analysis of cDNA clones from human cell line KG-1
26. Prediction of the coding sequences of unidentified human genes. V. The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of cDNA clones from human cell line KG-1
27. An antagonist decoy receptor and a death domain-containing receptor for TRAIL
28. Induction and stabilization of IκBα by nitric oxide mediates inhibition of NF- κB
29. Expression of laminin 5, fibronectin, and epithelium-associated integrins in recurrent aphthous ulcers
30. The role of exogenous/endogenous basic fibroblast growth factor (FGF2) and transforming growth factor beta (TGF beta-1) on human corneal endothelial cells proliferation in vitro
31. 3 integrin-induced endothelial cell survival
32. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors
33. Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of vWF to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura
34. Identification of the genes responsive to etoposide-induced apoptosis: Application of DNA chip technology
35. Von Willabrand factor -cleaving protease in thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome
36. Suppression of tumor growth with recombinant murine angiostatin
37. Vascular endothelial growth factor